I'm new here! Let me give you my background.. I'm 70 years old and was dx in September 2021,Gleason 9 - 4+5 / pT3bN1M1), PSA 198 with Pet CT PSMA F18, MR, Bone Scan.
No bone mets but multiple pelvic lymph nodes are positive and 5-6 distant lymph nodes in the abdominal region. Started ADT with Eligard shot, Abiraterone, Prednisone,Pantoprazole on Oct 15th.
On 23rd of November had new tests and PSA dropped to 6.8. I was elated by such a drop and upon a visit to my Dr he suggested radiation therapy.
I spoke with two Radiation Oncologists of which one suggested SBRT to the prostate and seminal vessels. My concern is how does that effect the lymph nodes which are not treated?
The other spoke with other doctors who confirmed being faced with a situation being out of the SOC because of the 5-6 distant lymph node mets where the STAMPEDE states max 3 distant mets. Being this situation and my excellent initial results with ADT they agreed upon continuing with ADT and beginning of February have another PET-CT PSMA to see if the distant mets reduce to 3 and then analyze what radiation will best. Probably SRBT to prostate and include distant mets.
Has anyone been through a similar situation with distant lymph node mets and what treatment was taken and how effective is it?
The situation is not easy because I understand the ADT can shrink the cancer but not kill. Is this true? If so Radiation seems like the next step.
We have LU-177 available here also but I was told to save this option only if needed.
I am doing everything I can and have the support of my wife and family but would greatly appreciate hearing about any experiences or information to help me take the right steps in this fight for survival and quality of live!
May all have a good Xmas and all the best!!
The trials that found that SBRT to the prostate is a waste of time if there are more than 3 distant metastases used bone scan/CT, not PSMA PET. It also was found using "de novo" metastatic patients, not patients whose metastases have been shrunken by systemic therapy. There is some early spread from the prostate, but later, most of the metastases grow from other metastases.
Abdominal metastases can be dangerous to irradiate, and it is highly doubtful that there is any benefit in doing that. Even small amounts of radiation can be very damaging to vital organs in the upper body.
When your cancer became metastatic, there were thousands of cancer cells that implanted themselves everywhere around your body. Most of them are way too small to detect with even the most sensitive scan (there is a 5mm size limit). Getting rid of some of the larger ones may or may not slow down spread of your cancer. If it is safe to "zap" them, why not? But if it is unsafe, as it may be in your case, the risk vastly outweighs the possible benefit.
However, SYSTEMIC therapy using advanced hormonals and/or docetaxel is known to slow progression and increase survival:
prostatecancer.news/2021/05...
Thank you for the information. I will consult this road with my Oncologist. The possible risks treating mets in the abdominal lymph nodes with SBRT was expressed by the Drs and the risks vs benefit seem to be questionable. The LU-177 therapy in my unknowing logic seems to be best because it targets the PSMA direct being able to avoid other areas. Still I get the idea that because it is a fairly new treatment doctors here prefer to go to SOC treatments and use LU-177 as an option when other treatments fail. Maybe because of the side effects??
In the US, Lu177PSMA617 will probably be approved next year, but only among men who have already had docetaxel and at least one advanced hormonal therapy. It will also only be approved among men who have significant PSMA avidity on a PSMA PET scan scan (which seems to be your case). In men who have high PSMA avidity, the side effects are usually tolerable. There are clinical trials for using it earlier. I don't know what the restrictions are in Brazil.